Reply: Growth differentiation factor 5 exerts neuroprotection in an α-synuclein rat model of Parkinson's disease and BMP5/7 protect dopaminergic neurons in an α-synuclein mouse model of Parkinson's disease
- PMID: 33257974
- DOI: 10.1093/brain/awaa369
Reply: Growth differentiation factor 5 exerts neuroprotection in an α-synuclein rat model of Parkinson's disease and BMP5/7 protect dopaminergic neurons in an α-synuclein mouse model of Parkinson's disease
Comment on
-
Randomized trial of intermittent intraputamenal glial cell line-derived neurotrophic factor in Parkinson's disease.Brain. 2019 Mar 1;142(3):512-525. doi: 10.1093/brain/awz023. Brain. 2019. PMID: 30808022 Free PMC article. Clinical Trial.
-
BMP5/7 protect dopaminergic neurons in an α-synuclein mouse model of Parkinson's disease.Brain. 2021 Mar 3;144(2):e15. doi: 10.1093/brain/awaa368. Brain. 2021. PMID: 33253359 Free PMC article. No abstract available.
-
Growth differentiation factor 5 exerts neuroprotection in an α-synuclein rat model of Parkinson's disease.Brain. 2021 Mar 3;144(2):e14. doi: 10.1093/brain/awaa367. Brain. 2021. PMID: 33253375 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
